FalchD.K., SchreinerA.The effect of spironolactone on lipid, glucose and uric acid levels in blood during long-term administration to hypertensives. Acta Med Scand1983; 213: 27–30
2.
AmeryA., LijnenP.Alterations in lipid metabolism induced by antihypertensive therapy. Drugs1988; 36(Suppl 2): 1–5
3.
CollinsR., PetoR., MacMahonS.Blood pressure, stroke, and coronary heart disease. Part 2, short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet1990; 335: 827–38
4.
Anonymous.ISIS-3-streptokinase the thrombolytic of choice. Scrip1991; No 1597: 22
